Larson Financial Group’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14 Hold
11
– – ﹤0.01% 3824
2026
Q2
$19 Sell
11
-4,055
-100% -$8.02K ﹤0.01% 3721
2026
Q1
$7.72K Hold
4,066
– – ﹤0.01% 2384
2025
Q4
$6.46K Buy
+4,066
New +$8.53K ﹤0.01% 2357

Other funds holding CRBU

Larson Financial Group's CRBU Position: Q3 2026 in Review

Larson Financial Group held its Caribou Biosciences (CRBU) position steady in Q3 2026 at 11 shares worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3824.

Larson Financial Group first reported a position in CRBU in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.72K in Q1 2026. 147 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

  • Larson Financial Group held 11 shares of Caribou Biosciences worth $14 as of Q3 2026.
  • Larson Financial Group left its Caribou Biosciences share count unchanged in Q3 2026.
  • Caribou Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3824 holding.
  • Larson Financial Group first reported a position in Caribou Biosciences in Q4 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Caribou Biosciences position peaked at $7.72K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.